{
    "nctId": "NCT03080493",
    "officialTitle": "Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial",
    "inclusionCriteria": "* 15 weeks 0 days gestational age - 23 weeks 5 days gestational age at time of dilator insertion\n* Able to read and write in English\n* Active cell phone with text messaging capability\n* Ride home from dilator insertion clinic appointment\n* Must be FEMALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Current use of gabapentin or pregabalin\n* Allergy to gabapentin, acetaminophen, codeine, or ibuprofen\n* Self reported renal disease (severe impaired renal function)\n* Self reported current or chronic narcotic use (typical daily use)\n* Women with any issue that, in the opinion of the investigator, would interfere with study participation or generating accurate study data"
}